Acute renal failure during sepsis: Potential role of cell cycle regulation

Journal of Infection

Volumn 58, Issue 6, 2009, Pages 459-464

  Yang, Quan hui ^a   Liu, Da wei ^a   Long, Yun ^a   Liu, Hong zhong ^a   Chai, Wen zhao ^a   Wang, Xiao Ting ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; DNA; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA CONTENT; FLOW CYTOMETRY; KIDNEY CELL; KIDNEY FUNCTION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PERITONITIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SEPSIS; WESTERN BLOTTING;

ANIMALS; CELL CYCLE; CREATININE; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DISEASE MODELS, ANIMAL; DNA; FLOW CYTOMETRY; G1 PHASE; KIDNEY FAILURE, ACUTE; MALE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RETINOBLASTOMA PROTEIN; S PHASE; SEPSIS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 65649094780     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.04.003     Document Type: Article

References (35)

1. Rice T.W., and Bernard G.R. Therapeutic intervention and targets for sepsis. Annu Rev Med 56 (2005) 225-248
2. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001) 1368-1377
3. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
4. Looney M.R., and Matthay M.A. Bench-to-bedside review: the role of activated protein C in maintaining endothelial tight junction function and its relationship to organ injury. Crit Care 10 (2006) 239
5. Riedemann N.C., Guo R.F., and Ward P.A. The enigma of sepsis. J Clin Invest 112 (2003) 460-467
6. Vincent J., Bota D., and De Backer D. Epidemiology and outcome in renal failure. Int J Artif Organs 27 (2004) 1013-1018
7. Cole L., Bellomo R., Silvester W., and Reeves J.H. A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in a "closed" ICU system. Am J Respir Crit Care Med 162 1 (2000) 191-196
8. Schrier R.W., and Wang W. Acute renal failure and sepsis. N Engl J Med 351 (2004) 159-169
9. Langenberg C., Bellomo R., May C., Wan L., Egi M., and Morgera S. Renal blood flow in sepsis. Crit Care 9 (2005) R363-R374
10. Uchino S., Doig G.S., Bellomo R., Morimatsu H., Morgera S., Schetz M., et al. Diuretics and mortality in acute renal failure. Crit Care Med 32 (2004) 1669-1677
11. Edelstein C.L., and Schrier R.W. Pathophysiology of ischemic acute renal failure. In: Schrier R.W. (Ed). Diseases of the kidney and urinary tract. 7th ed. vol. 2 (2001), Lippincott Williams & Wilkins, Philadelphia 1041-1069
12. Ympa Y., Sakr Y., Reinhart K., and Vincent J.-L. Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 118 (2005) 827-832
13. Toback F.G. Control of renal regeneration after acute tubule necrosis. In: Robinson R.R. (Ed). Nephrology (1984), Springer-Verlag, New York 748-762
14. Safirstein R., Zelent A.Z., and Gordon R. Cisplatin nephrotoxicity: new insights into mechanism. In: Hacker M.P., Lazo J.S., and Tritton T.R. (Eds). Organ directed toxicities of anticancer drugs (1988), Martinus Nijhoff, Boston, MA 172-189
15. Terada Y., Inoshita S., Nakashima O., Kuwahara M., Sasaki S., and Marumo F. Cyclins and the cyclin-kinase system - their potential roles in nephrology. Nephrol Dial Transplant 13 (1998) 1913-1916
16. Pines J. The cell cycle kinases. Semin Cancer Biol 5 (1994) 305-313
17. Pines J. Cyclins wheels within wheels. Cell Growth Differ 2 (1991) 305-310
18. Melk A. Senescence of renal cells: molecular basis and clinical implications. Nephrol Dial Transplant 18 (2003) 2474-2478
19. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempst P., et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78 (1994) 59-66
20. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., and Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 366 (1993) 701-704
21. Serrano M., Hannon G.J., and Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366 (1993) 704-707
22. Megyesi J., Safirstein R.L., and Price P.M. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101 (1998) 777-782
23. Megyesi J., Udvarhelyi N., Safirstein R.L., and Price P.M. The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am J Physiol Renal Fluid Electrolyte Physiol 271 (1996) F1211-F1216
24. Hubbard W.J., Choudhry M., Schwacha M.G., Kerby J.D., Rue III L.W., Bland K.I., et al. Cecal ligation and puncture. Shock 24 Suppl. 1 (2005) 52-57
25. Henry H.L. Metabolism of 25-hydroxy-vitamin D3 by primary cultures of chick kidney cells. Biochem Biophys Res Commun 74 (1977) 768-774
26. Fraker P.J., King L.E., Lill-Elghanian D., and Telford W.G. Quantification of apoptotic events in pure and hetero geneous populations of cells using the flow cytometer. Methods Cell Biol 46 (1995) 57-76
27. Daemen M.A., de Vries B., and Buurman W.A. Apoptosis and inflammation in renal reperfusion injury. Transplantation 73 (2002) 1693-1700
28. Guo R., Wang Y., Minto A.W., Quigg R.J., and Cunningham P.N. Acute renal failure in endotoxemia is dependent on caspase activation. J Am Soc Nephrol 15 (2004) 3093-3102
29. Wan L., Bagshaw S.M., Langenberg C., Saotome T., May C., and Bellomo R. Pathophysiology of septic acute kidney injury: what do we really know?. Crit Care Med 36 (2008) S198-S203
30. Lieberthal W., Fuhro R., Andry C.C., Rennke H., Abernathy V.E., Koh J.S., et al. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 281 (2001) F693-F706
31. Mercer W.E., Avignolo C., and Baserga R. Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies. Mol Cell Biol 4 (1984) 276-281
32. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G1 cyclin dependent kinases. Genes Dev 9 (1995) 1149-1163
33. Feliers D., Frank M.A., and Riley D.J. Activation of cyclin D1/Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy. Diabetes 51 (2002) 3290-3299
34. Katrien V., Dirk R.V., and Zwi N.B. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36 (2003) 131-149
35. Park S.K., Kim W., Lee C.H., and Koh G.Y. Differential changes of CDK activities in glomeruli and tubules during the active DNA synthetic period after ischemic injury. Nephron 86 (2002) 306-314